Robert B Borucki (Robert Borucki)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Prognostic Factors

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Lupus science & medicine

Expert review of clinical pharmacology

The Laryngoscope

This page only lists publications with an associated author ORCID identifier.

Publications

Daisy Yan, Robert B Borucki, Richard D Sontheimer, Victoria P Werth
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus. Lupus science & medicine 7 (1) (2021)
Robert B Borucki, Victoria P Werth
Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'. Expert review of clinical pharmacology 13 (8) (2020)
Robert B Borucki, Victoria P Werth
Expert Perspective: An Evidence-Based Approach to Refractory Cutaneous Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 72 (11) (2020)
Robert B Borucki, David M Neskey, Eric J Lentsch
Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck. The Laryngoscope 128 (4) (2017)